Janux Therapeutics Inc (JANX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.37B
P/E Ratio
0.00
Revenue (TTM)
$ 439K
Volume
0
52W High
$ 71.71
52W Low
$ 22.25
Dividend Yield
0.00%
Beta
2.85
Technicals
50-Day MA
24.7083
200-Day MA
36.6051
52 Week High
71.71
52 Week Low
22.25
About JANX
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms t.
Employees
81
Headquarters
San Diego, CA
CEO
Dr. David Alan Campbell Ph.D.
Latest News
Janux Therapeutics Earns Buy Rating Amid Promising Pipeline and Strong Financial Position. - AInvest
12 hours ago • Google News
Janux (JANX) R&D Soars Revenue Misses - AOL.com
3 days ago • Google News